Summary
In countries with low tuberculosis (TB) incidence, TB is concentrated in vulnerable populations, including people living with HIV (PLHIV) who have a substantially greater risk of TB than people without HIV.
We searched PubMed, EMBASE and Web of Science for studies evaluating risk factors for latent TB infection (LTBI) or active TB in PLHIV in countries with TB incidence ≤10/100,000 population. Due to the number of risk factors evaluated and heterogeneity in study designs, we present summary data and a narrative synthesis. We included 45 studies; 17 reported data on risk factors for LTBI and 32 on active TB. Black, Asian or Hispanic ethnicity, birth or long-term residence in a country with high TB incidence, and HIV acquisition via injecting drug use or heterosexual sex were strong predictors of both LTBI and active TB. History of contact, a greater degree of immunosuppression at diagnosis or higher viral load increased TB risk.
Introduction
HIV is an important risk factor for tuberculosis (TB) disease; globally, people living with HIV (PLHIV) are at an estimated 26-31 times higher risk of TB than people without HIV infection. 1 HIV co-infection is associated with higher rates of progression from latent to active TB, more severe disease presentation, worse clinical outcomes and increased mortality. An estimated 12.5% of new TB cases in 2014 were among PLHIV and TB is the leading cause of death for PLHIV; responsible for around one third of deaths. 2 Globally, HIV-associated TB (HIV-TB) is concentrated in sub-Saharan Africa, which accounted for around three quarters of HIV-TB morbidity and mortality in 2015. 3 HIV-TB co-infection also remains a persistent public health problem in low TB incidence countries (defined by the World Health Organization [WHO] as less than 10 cases per 100,000 population), 4 where the changing epidemiology of TB has led to a concentration of disease in high risk groups. In 2012, an estimated 155,000 people fell ill with TB in low-incidence countries and 10,000 people died. 5 TB transmission in the general population in low-incidence countries is generally minimal, with the majority of cases occurring in patients born abroad as a result of progression from previously acquired latent infection. 6 In addition to PLHIV, there is a disproportionate burden of TB among vulnerable populations such as recent migrants (particularly those from countries with high TB incidence) and people who are homeless, incarcerated, or have problems with substance abuse. 5 These sub-populations are often referred to as "hard to reach", linked by poverty, social deprivation and difficulties accessing healthcare. 7 Priority areas of the WHO's action framework for TB in low-incidence countries include addressing TB in the most vulnerable and hard-to-reach groups, screening for latent and active TB in high-risk groups and ensuring continued patient-level surveillance and evaluation. 4 There is considerable overlap between these at-risk groups, as many people have multiple risk factors, and/or difficulties accessing healthcare services. Systematic screening of PLHIV for active TB is recommended, but is not done in all low-incidence countries. 4 Systematic screening for LTBI is also recommended for PLHIV and other highrisk groups, but not widely implemented. 4 Efforts to control HIV-TB are hampered by the significant proportion of PLHIV who are undiagnosed, diagnosed late, or not diagnosed until they present to healthcare service with other opportunistic infections such as TB. Managing TB in PLHIV is also more clinically complex, as a result of side effects of treatment, drug-drug interactions, and often a more severe presentation of disease. 8 Preventing TB in PLHIV is therefore of paramount importance. However diagnosing LTBI in PLHIV can be difficult, as diagnostic tests for LTBI (particularly the tuberculin skin test [TST]) are less sensitive at low CD4 counts. 9 Furthermore, pressure on resources, even in countries with low TB incidence, necessitates the targeting of preventative activities such as screening for LTBI and active TB. It is therefore critical to have a clear insight into risk factors for TB disease in PLHIV in countries with low TB incidence. This review provides an up-to-date synthesis of the evidence on risk factors for LTBI and TB disease among PLHIV.
Methods
We systematically searched PubMed, EMBASE and Web of Science on 4 th May 2017 for articles on risk factors for LTBI or active TB disease among people living with HIV in countries with low TB incidence (defined as ≤10 cases per 100,000 population, based on 2015 WHO data). 4 The search terms included variations of "tuberculosis", "HIV" and the lowincidence countries; full details of the search strategy and results are shown in Appendix 1.
We excluded studies presenting data on multi-country cohorts if any country contributing to the cohort did not have low TB incidence. No limits were placed on year or language of publication.
The search results were de-duplicated and screening was done by title, abstract and then full-text, by two reviewers (JW and AA) with 10% overlap. Any disagreements were resolved by consensus. The reference lists of included articles and relevant review articles were screened for additional papers. We provide a narrative synthesis of our findings. The review was registered on PROSPERO (CRD42017069544).
Findings and Implications

Search results and included studies
After de-duplication, the search yielded 5,804 results. After title, abstract and full-text screening, 45 studies were included ( Figure 1 ). Initial reviewer agreement was 99.3%, resolved to 100% after comparing the discrepant papers against the inclusion criteria. Of the 45 included studies (summarised in detail in supplementary table 1), 17 provided data on risk factors for LTBI, 10-26 32 included data on risk factors for active TB, and 4 studies contained data on both. 23 
Sociodemographic factors associated with tuberculosis Sex
Globally, the risk of TB is higher for men than women, 55 however data on the effect of sex on risk of TB among PLHIV in this review were mixed. Of the nine studies which reported no association between sex and risk of LTBI, none adjusted for other factors such as route of HIV infection, which may have biased associations of risk of TB towards women; people who acquire HIV through heterosexual sex usually have higher rates of TB than MSM, as black African ethnicity and birth in countries with high TB incidence can be confounders for route of HIV infection. The HIV epidemic in sub-Saharan Africa disproportionately affects women, whilst the Western epidemic has predominantly affected men who have sex with men. As HIV-TB in low-incidence settings is mainly an issue for migrants from high-incidence countries, the higher number of heterosexual women than men diagnosed with HIV affects that observed patterns of HIV-TB.
Ethnicity and Country of Birth
We found that the risk of both LTBI and active TB was greatest among PLHIV from ethnic minorities; particularly those of black African, South Asian or Hispanic ethnicity. 13, 15, 17, 19, 23, 25, 31, 32, 37, 43, 44, 46, 49, 52, 53 Similarly, PLHIV who were born in, or long-term residents of, countries with high TB incidence had higher rates of LTBI and active TB. [10] [11] [12] [13] 17, 18, [22] [23] [24] 26, 45, 56 Few studies examined the effects of country of birth and ethnicity independently of each other; those that did found no independent associations between ethnicity and country of birth and active TB 34, 46 or LTBI. 14, 17 However, a more recently published study stratified the risk of developing active TB by ethnicity and the TB incidence in country of birth and demonstrated that ethnicity and the incidence of TB in the patient's country of birth independently increase the risk of developing TB for PLHIV. TB incidence among black African PLHIV born in high-incidence countries was higher than that of PLHIV with only one of these risk factors. 57 Both ethnicity and country of birth are proxy measures for long-term exposure to TB; visiting a TB-endemic country was not associated with the risk of LTBI, although the association between the length of visit and risk of LTBI was not explored. 45 One study observed that the risk of TB among migrants decreased with increasing time since entry to the country. This could reflect reversion of previously acquired infection, as the risk of LTBI in PLHIV born abroad decreased with time since migration. 45 It could also be attributed to the fact that there is an increased risk of TB amongst people who were infected with HIV abroad, 46 and that the likelihood of HIV infection remaining undiagnosed decreases with time, and therefore the risk of TB decreases as patients become aware of their HIV infection and initiate ART. This is supported by the fact that the risk of active TB increased with increasing time from entry to the study country to HIV diagnosis. 41 As the majority of PLHIV born abroad are likely to have been infected with HIV in their country of birth, 58 the increased risk of TB with time from migration to HIV diagnosis is likely a reflection of late HIV diagnosis and low CD4 count.
Route of HIV infection
Both LTBI and active TB were more likely to occur in study participants who acquired their HIV infection through heterosexual sex, injecting drug use or mother-to-child transmission than by sex between men, and having a partner who injected drugs was also associated with increased risk of LTBI. 15, 19, 24, 26, 31, 32, 34, 35, 38, 41, 51 Children with TB were more likely to have mothers who acquired HIV through injecting drug use than heterosexual sex or other routes of transmission, compared to HIV-infected children without TB. 52 Injecting drug use was associated with increased risk of TB, 33, 43, 49 as was long term tobacco use, 39 however alcohol misuse was not. 59 It is likely that routes of HIV infection other than sex between men are confounders for exposure to TB, which was an important risk factor for both LTBI and active TB, but one which few studies examined directly. In particular, HIV acquisition through heterosexual sex is strongly correlated with birth in countries with high TB incidence, 60 discussed previously.
Other social risk factors
Homelessness, and living or working in a collective group or institution, were associated with higher risks of LTBI, 10, 13, 18, 19 Proximity to persons with TB was also important; close contact with a TB case increased the risk of LTBI 10, 11, 19, 21, 45 and active TB, 25, 29, 40 and a study set in a prison demonstrated that closer proximity was associated with increased risk. 25
Clinical risk factors for HIV-TB CD4 count, viral load and ART
CD4 counts of <500 cells/µl were overwhelmingly inversely associated with greater risk of developing active TB. 23, 24, 27, 28, 30, 31, [33] [34] [35] [36] [37] [38] [42] [43] [44] 46, [49] [50] [51] ART was highly protective against active TB for PLHIV, 24, 27, 30, 34, 35, 46, 51 with a time-dependent decrease in risk of TB during ART documented in multiple studies. 27, 31, 43, 44 Conversely, though the data were conflicting, high viral loads were associated with increased risk of active TB in most studies. 27, 31, 32, 35, 36 Together, these findings highlight the fundamental importance of early diagnosis and treatment of HIV in preventing HIV-TB. As recommended in existing guidelines, this may require screening programmes to be implemented in groups of people at high risk.
LTBI
Anergic patients and patients with a positive TST result had significantly higher risk of TB than TST-negative and/or non-anergic patients. 24, 28, 30, 38, 47, 48 However, diagnosing LTBI in PLHIV is challenging, particularly among those with low CD4 counts. There was no consistent association with the risk of LTBI for CD4 count, HIV viral load, or ART. Low CD4 count was not associated with an increased risk of LTBI among PLHIV, [10] [11] [12] 17, 22 and some studies (particularly those which used TSTs to diagnose LTBI) reported higher rates of LTBI in participants with high CD4 counts. 14, 16, 24, 26 This is likely due to lower sensitivity of diagnostic tests for LTBI at lower CD4 counts, which is well documented for TSTs but less so for interferon-gamma release assays (IGRAs). This difficulty diagnosing LTBI at low CD4 count means that it is not established as to whether HIV increases the risk of becoming infected with TB (as opposed to progression to active disease, the evidence for which is definitive). Known LTBI was associated with increased risk of TB disease, 24, 28, 30, 38, 47, 48 although this risk was lessened by preventive therapy. 24, 26, 47 A longer duration of preventive therapy was more protective. 48 The difficulty diagnosing LTBI at low CD4 counts means that preventive TB therapy for PLHIV at high risk of exposure to pulmonary TB patients is important, since low CD4 counts can prevent diagnosis of LTBI and there is a high risk of progression to active TB if latent infection is established.
History of previous TB
Two studies examined the relationship between prior active TB disease and the risk of active TB; an observational cohort reported that prior TB was associated with higher risk of TB, 28 however a study in a prison of an outbreak which occurred as a result of infection from a single source patient found no association between prior TB and risk of TB. This may suggest that prior TB increases the risk of active TB either because it is a marker for other risk factors relating to risk of exposure to TB or progression from LTBI to active TB. These factors could include higher background rates of TB, low CD4 count, unsuccessful treatment of prior disease or development of drug resistance during treatment of the previous disease.
Strengths and limitations of the study design and findings
The systematic search strategy enabled a comprehensive review of the literature.
Due to the high number of records found by our search, 10% of results were screened by two reviewers. Between-reviewer agreement was high and the discrepant articles were generally excluded after reviewing them against the inclusion criteria. Accordingly, our strategy demonstrated a high sensitivity.
For the purposes of our inclusion criteria, countries were defined as 'low incidence' based on the TB incidence of TB in 2015; this was a pragmatic choice as many studies spanned several years and TB incidence changed over time. Consequently we may have included studies from periods where the TB incidence was above 10/100,000 population, or excluded studies conducted where TB incidence was less than 10/100,000 prior to 2015 but not in 2015. This is particularly relevant for small countries, where a small change in the number of cases reported could result in a substantial fluctuation in incidence. We excluded multi-country studies where not all the countries had low TB incidence and data were not presented stratified by country, which led to the exclusion of some large studies of active TB incidence among PLHIV. However, the findings of these studies were consistent with those of this review; the HIV-CAUSAL study, the EuroSIDA cohort and the ART Cohort Collaboration reported that higher TB incidence was associated with low CD4 count, high viral load, HIV acquisition by injecting drug use or heterosexual sex (compared to MSM), and being born in Africa. [61] [62] [63] [64] We did not report on the magnitude of associations between the various risk factors and LTBI or active TB due to the considerable heterogeneity in the design and statistical analyses of the included studies, particularly variation in how variables were categorised, which category was used as the baseline, and which other variables (if any) were adjusted for. There were no clear differences in the directions of associations between risk factors and the outcome in studies which conducted multivariable analyses and those which only reported univariable associations; accordingly, this does not appear to be a source of bias.
The majority of studies were large cohorts or utilised national surveillance data and so would have used standard definitions for active TB, although this was generally not stated specifically.
The majority of the literature included in this review was from Western Europe and North America. The risk factors for TB in PLHIV discussed here may therefore not be generalisable to other low-incidence settings with different migration patterns, such as Australia. Many of the risk factors for TB identified in this study will also apply to people who are not infected with HIV. In particular, people born in countries with high TB incidence have high rates of TB even without HIV infection. Consequently, incorporating HIV testing and care into screening programmes targeted to those at high risk of TB is important to ensure that preventive measures are being offered to all those with a high risk of TB.
Opportunities for Prevention Early HIV diagnosis and ART initiation
Early diagnosis of HIV is fundamental to the prevention of HIV-TB, as early initiation of ART is highly protective against TB disease. Early diagnosis of HIV also provides an opportunity to test and treat PLHIV for LTBI before active TB can develop. However, there are challenges at all stages of the continuum of HIV care; diagnosing HIV, linking patients to HIV care, initiating ART, and viral suppression. This highlights the importance of the UNAIDS 90-90-90 targets. 65 Despite the UK exceeding the overall UNAIDS target for the proportion of PLHIV that are virally suppressed, a substantial number of TB diagnoses in PLHIV are in people who are not aware of their HIV infection prior to their TB diagnosis. 46, 57 Scale-up of targeted HIV testing of populations at high risk of both HIV and TB disease such as migrants from high-burden countries and people who inject drugs may facilitate earlier diagnosis of HIV, which may allow prevention of many cases of TB among these populations.
HIV testing could also be incorporated alongside screening initiatives for other diseases with overlapping risk profiles, including TB, hepatitis B and C. These may including active case finding programmes targeting vulnerable groups (including the homeless, prisoners, high-risk drug users and migrants). 66 One study found that HIV-positive children with TB were more likely to have mothers who acquired HIV through injecting drug use than through heterosexual sex or other routes of transmission than HIV-positive children without TB. This suggests that antenatal HIV screening and preventive treatment for TB are not being effectively delivered to "hard to reach" women who acquired HIV infection through injecting drug use, resulting in a higher risk of TB for their children than for the children of heterosexual women with HIV. Improving support to access antenatal HIV screening could help prevent mother-to-child HIV transmission in hard to reach populations and reduce the susceptibility of mothers and their children to TB.
Pre-entry screening of migrants from countries with high TB incidence for pulmonary TB is now required for migrants moving to the UK, Australia, Canada, New Zealand and the USA, and other countries could consider adopting these guidelines to reduce the incidence of active TB. However, this strategy cannot prevent TB among migrants who arrive via irregular routes (who may be among those at highest risk of disease), and pre-entry screening does not include testing for LTBI or HIV. Promoting integrated screening for HIV infection and LTBI to migrants from countries with high TB incidence, particularly those who have recently entered the country, could also be an effective measure to both diagnose HIV sooner and prevent LTBI from progressing into active TB disease.
LTBI testing and treatment for PLHIV
Recent clinical trials in high TB-incidence settings have demonstrated the efficacy of isoniazid preventive therapy for reducing TB incidence among PLHIV. 67 However, in lowincidence settings, there are challenges in determining who should be offered preventive therapy, and in increasing uptake of testing and treatment for LTBI. 68 In low-incidence settings, the WHO recommend systematic testing for and treatment of LTBI among PLHIV, 4 prioritising those with recent infection, and those who have recently migrated from high-to low-burden settings. National guidelines have followed suit, with the CDC recommending testing all PLHIV for LTBI at the time of HIV diagnosis, and treating those who test positive or who are close contacts of infectious pulmonary TB patients. 69 For PLHIV who are diagnosed with HIV with a CD4 count <200 cells/µl, the CDC also recommend re-testing for LTBI once the CD4 count has risen to ≥200. 69 Similarly, the UK recommend screening PLHIV for LTBI according to criteria based on CD4 count, time on ART, and country of birth; 70,71 however, these guidelines are not widely implemented. 68 Further research is required to understand whether the barriers to testing and treating LTBI are occurring at the clinic level (i.e., whether testing and treatment for LTBI are being offered) or at the patient level, and how these barriers can be overcome to improve the uptake of LTBI testing and treatment.
Systematic screening for active TB
The WHO recommend screening for active TB in high-risk groups, such as PLHIV, due to both the high risk of developing TB and the high likelihood of severe consequences if TB diagnosis and treatment are delayed. 4 Earlier diagnosis of active TB as a result of screening programmes may also reduce onwards transmission. General WHO guidance on systematic screening for active tuberculosis includes a strong recommendation to screen PLHIV for active TB at each visit to a health facility. 72 In low-incidence settings (where the majority of PLHIV are receiving ART and virologically suppressed), this is unlikely to be an efficient use of resources; indeed the WHO action framework for low-incidence countries 4 does not specify the frequency at which PLHIV should be screened for active TB. The risk of TB has been shown to decrease over time following HIV diagnosis, 27, 35, 57 therefore screening for active TB at, or soon after, HIV diagnosis may be the most efficient use of resources.
Cost-effectiveness analyses would be useful to investigate the efficacy and impact of such screening programmes, to inform guidelines. 142 not conducted solely in low-incidence setting 138 no data on risk factors 53 not original research 47 all patients had TB 19 outcome not TB 9 study population was not PLHIV 
Risk factor for LTBI Summary of results
Sociodemographic factors
Age Greater risk with increasing age: 1 study 19 QFT-GIT-positive participants were significantly younger than QFT-GIT-negative participants: 1 study 11 No association: 11 studies 10, 12, 13, [16] [17] [18] [21] [22] [23] [24] 45 Ethnicity Greater risk for black participants than white participants: 4 studies 15, 17, 19, 23 Greater risk for Asian participants than white participants: 2 studies 13, 17 Greater risk for Hispanic participants than white participants: 1 study 15 No association: 2 studies 18, 22 Country of birth or residence Greater risk of LTBI in participants who were born abroad: 4 studies 13, 21, 23, 24 Greater risk of LTBI in participants born in Africa: 3 studies 23, 24, 26 Greater risk for participants who were born or long-term residents in countries with high TB incidence: 7 studies [10] [11] [12] 17, 18, 22, 45 Risk of TB decreased with time since migration: 1 study 45 No association with visiting a TB-endemic country: 1 study 45 
Sex
Greater risk for women: 2 studies 10, 23 Greater risk for men: 1 study 24 No association: 9 studies [11] [12] [13] [15] [16] [17] [18] 22, 45 Single-sex studies: 4 studies 14, 19, 21, 25 Pregnancy No association: 1 study 19 All participants were pregnant: 1 study 21
Route of HIV infection
Higher rates of TST positivity among people who inject drugs and/or have a partner who injects drugs: 2 studies 15, 24 Higher rates of TST positivity among people who acquired HIV through heterosexual sex than by sex between men: 1 study 24 Significant, but not described, differences in risk by infection route: 1 study 26 No association: 2 studies 22, 23 Drug misuse Higher rates of illicit drug use amongst TST-positive participants than TST-negative participants: 1 study 19 No association between injecting or recreational drug use and 
Summary of results
Sociodemographic factors
